Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2022

Publisher Name :
Date: 14-May-2022
No. of pages: 101
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Solid Microneedles

- Hollow Microneedles

- Dissolving Microneedles

Segment by Application

- Hospitals

- Ambulatory Surgical Centers

- Specialty Clinics

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- 3M

- Becton

- Endoderma

- BD

- Zosano Pharma

- Raphas

- Nanopass Tech

- Corium International

- Valeritas

- Nitto Denko

- Microdermics

- TheraJect

- Vaxxas

- KINDEVA

- QuadMedicine

- SNvia

- Small Lab

- Lohmann Therapie-Systeme

- AdminMed Nano BioSciences

Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2022

Table of Contents
1 Microarray Patch Transdermal Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Microarray Patch Transdermal Drug Delivery Systems
1.2 Microarray Patch Transdermal Drug Delivery Systems Segment by Type
1.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Solid Microneedles
1.2.3 Hollow Microneedles
1.2.4 Dissolving Microneedles
1.3 Microarray Patch Transdermal Drug Delivery Systems Segment by Application
1.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Microarray Patch Transdermal Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue 2017-2028
1.4.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales 2017-2028
1.4.3 Microarray Patch Transdermal Drug Delivery Systems Market Size by Region: 2017 Versus 2021 Versus 2028
2 Microarray Patch Transdermal Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Microarray Patch Transdermal Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
2.5 Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Microarray Patch Transdermal Drug Delivery Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Microarray Patch Transdermal Drug Delivery Systems Players Market Share by Revenue
2.5.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.3.1 North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country
3.3.2 North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.4.1 Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country
3.4.2 Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Region
3.5.2 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country
3.6.2 Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country
3.7.2 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Microarray Patch Transdermal Drug Delivery Systems Historic Market Analysis by Type
4.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2017-2022)
4.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Type (2017-2022)
4.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2017-2022)
5 Global Microarray Patch Transdermal Drug Delivery Systems Historic Market Analysis by Application
5.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2017-2022)
5.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Application (2017-2022)
5.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2017-2022)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Becton
6.2.1 Becton Corporation Information
6.2.2 Becton Description and Business Overview
6.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.2.5 Becton Recent Developments/Updates
6.3 Endoderma
6.3.1 Endoderma Corporation Information
6.3.2 Endoderma Description and Business Overview
6.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.3.5 Endoderma Recent Developments/Updates
6.4 BD
6.4.1 BD Corporation Information
6.4.2 BD Description and Business Overview
6.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Zosano Pharma
6.5.1 Zosano Pharma Corporation Information
6.5.2 Zosano Pharma Description and Business Overview
6.5.3 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.5.5 Zosano Pharma Recent Developments/Updates
6.6 Raphas
6.6.1 Raphas Corporation Information
6.6.2 Raphas Description and Business Overview
6.6.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.6.5 Raphas Recent Developments/Updates
6.7 Nanopass Tech
6.6.1 Nanopass Tech Corporation Information
6.6.2 Nanopass Tech Description and Business Overview
6.6.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.7.5 Nanopass Tech Recent Developments/Updates
6.8 Corium International
6.8.1 Corium International Corporation Information
6.8.2 Corium International Description and Business Overview
6.8.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.8.5 Corium International Recent Developments/Updates
6.9 Valeritas
6.9.1 Valeritas Corporation Information
6.9.2 Valeritas Description and Business Overview
6.9.3 Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Valeritas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.9.5 Valeritas Recent Developments/Updates
6.10 Nitto Denko
6.10.1 Nitto Denko Corporation Information
6.10.2 Nitto Denko Description and Business Overview
6.10.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.10.5 Nitto Denko Recent Developments/Updates
6.11 Microdermics
6.11.1 Microdermics Corporation Information
6.11.2 Microdermics Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.11.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.11.5 Microdermics Recent Developments/Updates
6.12 TheraJect
6.12.1 TheraJect Corporation Information
6.12.2 TheraJect Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.12.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.12.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.12.5 TheraJect Recent Developments/Updates
6.13 Vaxxas
6.13.1 Vaxxas Corporation Information
6.13.2 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.13.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.13.5 Vaxxas Recent Developments/Updates
6.14 KINDEVA
6.14.1 KINDEVA Corporation Information
6.14.2 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.14.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.14.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.14.5 KINDEVA Recent Developments/Updates
6.15 QuadMedicine
6.15.1 QuadMedicine Corporation Information
6.15.2 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.15.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.15.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.15.5 QuadMedicine Recent Developments/Updates
6.16 SNvia
6.16.1 SNvia Corporation Information
6.16.2 SNvia Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.16.3 SNvia Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.16.4 SNvia Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.16.5 SNvia Recent Developments/Updates
6.17 Small Lab
6.17.1 Small Lab Corporation Information
6.17.2 Small Lab Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.17.3 Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Small Lab Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.17.5 Small Lab Recent Developments/Updates
6.18 Lohmann Therapie-Systeme
6.18.1 Lohmann Therapie-Systeme Corporation Information
6.18.2 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.18.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.18.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.19 AdminMed Nano BioSciences
6.19.1 AdminMed Nano BioSciences Corporation Information
6.19.2 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
6.19.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
6.19.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
6.19.5 AdminMed Nano BioSciences Recent Developments/Updates
7 Microarray Patch Transdermal Drug Delivery Systems Manufacturing Cost Analysis
7.1 Microarray Patch Transdermal Drug Delivery Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Microarray Patch Transdermal Drug Delivery Systems
7.4 Microarray Patch Transdermal Drug Delivery Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Microarray Patch Transdermal Drug Delivery Systems Distributors List
8.3 Microarray Patch Transdermal Drug Delivery Systems Customers
9 Microarray Patch Transdermal Drug Delivery Systems Market Dynamics
9.1 Microarray Patch Transdermal Drug Delivery Systems Industry Trends
9.2 Microarray Patch Transdermal Drug Delivery Systems Market Drivers
9.3 Microarray Patch Transdermal Drug Delivery Systems Market Challenges
9.4 Microarray Patch Transdermal Drug Delivery Systems Market Restraints
10 Global Market Forecast
10.1 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Type (2023-2028)
10.2 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Application (2023-2028)
10.3 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Microarray Patch Transdermal Drug Delivery Systems Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation by Manufacturers in 2021
Table 5. Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Microarray Patch Transdermal Drug Delivery Systems Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Microarray Patch Transdermal Drug Delivery Systems Manufacturing Sites and Area Served
Table 11. Manufacturers Microarray Patch Transdermal Drug Delivery Systems Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Microarray Patch Transdermal Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microarray Patch Transdermal Drug Delivery Systems as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region (2017-2022) & (K Units)
Table 16. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region (2017-2022)
Table 17. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region (2017-2022)
Table 19. North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 20. North America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 21. North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 23. Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 24. Europe Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 25. Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region (2017-2022)
Table 31. Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 33. Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
Table 39. Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2017-2022) & (K Units)
Table 40. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2017-2022)
Table 41. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Type (2017-2022)
Table 43. Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units) by Application (2017-2022)
Table 45. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2017-2022)
Table 46. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Application (2017-2022)
Table 48. Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2017-2022) & (US$/Unit)
Table 49. 3M Corporation Information
Table 50. 3M Description and Business Overview
Table 51. 3M Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. 3M Microarray Patch Transdermal Drug Delivery Systems Product
Table 53. 3M Recent Developments/Updates
Table 54. Becton Corporation Information
Table 55. Becton Description and Business Overview
Table 56. Becton Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Becton Microarray Patch Transdermal Drug Delivery Systems Product
Table 58. Becton Recent Developments/Updates
Table 59. Endoderma Corporation Information
Table 60. Endoderma Description and Business Overview
Table 61. Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Endoderma Microarray Patch Transdermal Drug Delivery Systems Product
Table 63. Endoderma Recent Developments/Updates
Table 64. BD Corporation Information
Table 65. BD Description and Business Overview
Table 66. BD Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. BD Microarray Patch Transdermal Drug Delivery Systems Product
Table 68. BD Recent Developments/Updates
Table 69. Zosano Pharma Corporation Information
Table 70. Zosano Pharma Description and Business Overview
Table 71. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Product
Table 73. Zosano Pharma Recent Developments/Updates
Table 74. Raphas Corporation Information
Table 75. Raphas Description and Business Overview
Table 76. Raphas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Raphas Microarray Patch Transdermal Drug Delivery Systems Product
Table 78. Raphas Recent Developments/Updates
Table 79. Nanopass Tech Corporation Information
Table 80. Nanopass Tech Description and Business Overview
Table 81. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product
Table 83. Nanopass Tech Recent Developments/Updates
Table 84. Corium International Corporation Information
Table 85. Corium International Description and Business Overview
Table 86. Corium International Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Corium International Microarray Patch Transdermal Drug Delivery Systems Product
Table 88. Corium International Recent Developments/Updates
Table 89. Valeritas Corporation Information
Table 90. Valeritas Description and Business Overview
Table 91. Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Valeritas Microarray Patch Transdermal Drug Delivery Systems Product
Table 93. Valeritas Recent Developments/Updates
Table 94. Nitto Denko Corporation Information
Table 95. Nitto Denko Description and Business Overview
Table 96. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product
Table 98. Nitto Denko Recent Developments/Updates
Table 99. Microdermics Corporation Information
Table 100. Microdermics Description and Business Overview
Table 101. Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Microdermics Microarray Patch Transdermal Drug Delivery Systems Product
Table 103. Microdermics Recent Developments/Updates
Table 104. TheraJect Corporation Information
Table 105. TheraJect Description and Business Overview
Table 106. TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. TheraJect Microarray Patch Transdermal Drug Delivery Systems Product
Table 108. TheraJect Recent Developments/Updates
Table 109. Vaxxas Corporation Information
Table 110. Vaxxas Description and Business Overview
Table 111. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product
Table 113. Vaxxas Recent Developments/Updates
Table 114. KINDEVA Corporation Information
Table 115. KINDEVA Description and Business Overview
Table 116. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product
Table 118. KINDEVA Recent Developments/Updates
Table 119. QuadMedicine Corporation Information
Table 120. QuadMedicine Description and Business Overview
Table 121. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product
Table 123. QuadMedicine Recent Developments/Updates
Table 124. SNvia Corporation Information
Table 125. SNvia Description and Business Overview
Table 126. SNvia Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. SNvia Microarray Patch Transdermal Drug Delivery Systems Product
Table 128. SNvia Recent Developments/Updates
Table 129. Small Lab Corporation Information
Table 130. Small Lab Description and Business Overview
Table 131. Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Small Lab Microarray Patch Transdermal Drug Delivery Systems Product
Table 133. Small Lab Recent Developments/Updates
Table 134. Lohmann Therapie-Systeme Corporation Information
Table 135. Lohmann Therapie-Systeme Description and Business Overview
Table 136. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product
Table 138. Lohmann Therapie-Systeme Recent Developments/Updates
Table 139. AdminMed Nano BioSciences Corporation Information
Table 140. AdminMed Nano BioSciences Description and Business Overview
Table 141. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product
Table 143. AdminMed Nano BioSciences Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Microarray Patch Transdermal Drug Delivery Systems Distributors List
Table 147. Microarray Patch Transdermal Drug Delivery Systems Customers List
Table 148. Microarray Patch Transdermal Drug Delivery Systems Market Trends
Table 149. Microarray Patch Transdermal Drug Delivery Systems Market Drivers
Table 150. Microarray Patch Transdermal Drug Delivery Systems Market Challenges
Table 151. Microarray Patch Transdermal Drug Delivery Systems Market Restraints
Table 152. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Type (2023-2028)
Table 154. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Application (2023-2028)
Table 158. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Region (2023-2028)
Table 162. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Microarray Patch Transdermal Drug Delivery Systems
Figure 2. Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Type in 2021 & 2028
Figure 3. Solid Microneedles Product Picture
Figure 4. Hollow Microneedles Product Picture
Figure 5. Dissolving Microneedles Product Picture
Figure 6. Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Appl
  • Global Zebrafish Market Research Report 2022
    Published: 21-May-2022        Price: US 2900 Onwards        Pages: 99
    Market Analysis and Insights: Global Zebrafish Market The global Zebrafish market size is projected to reach US$ 231.50 million by 2028, from US$ 89.65 million in 2021, at a CAGR of 14.51% during 2022-2028. Fully considering the economic change by this health crisis, Toxicity Testing Services accounting for 18.37% of the Zebrafish global market in 2021, is projected to value US$ 96.22 million by 2028, growing at a revised 13.94% CAGR in the post-COVID-19 period. While Pharmaceutica......
  • Global and United States 3D Cone Beam CT System Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 100
    3D Cone Beam CT System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global 3D Cone Beam CT System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the 3D Cone Beam CT System market size by......
  • Global and United States Pharmaceutical Membrane Filters Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 104
    Pharmaceutical Membrane Filters market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Membrane Filters market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Pharmaceutical Memb......
  • Global and United States Medicine Packaging Machines Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 105
    Medicine Packaging Machines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Medicine Packaging Machines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Medicine Packaging Machines......
  • Global and United States Liposuction Equipment Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 118
    Liposuction Equipment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Liposuction Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Liposuction Equipment market size by pl......
  • Global and United States Absorbable Suture Anchor Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 126
    Absorbable Suture Anchor market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Absorbable Suture Anchor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Absorbable Suture Anchor market s......
  • Global and United States Drug Adherence Packaging System Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 100
    Drug Adherence Packaging System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug Adherence Packaging System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Drug Adherence Pack......
  • Global and United States Animal Ultrasound Scanner Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 103
    Animal Ultrasound Scanner market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Animal Ultrasound Scanner market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Animal Ultrasound Scanner marke......
  • Global and United States Human Liver Model Market Report & Forecast 2022-2028
    Published: 20-May-2022        Price: US 4350 Onwards        Pages: 92
    Human Liver Model market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Liver Model market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Human Liver Model market size by players, by Ty......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs